A new strain of Epstein-Barr virus derived from nasopharyngeal carcinoma hybrid cells.
A new strain of Epstein-Barr virus was isolated from an epithelioid hybrid cell line derived from nasopharyngeal carcinoma which had been cultured for 14 days at 32 degrees. This virus can transform human cord blood lymphocytes and induce early antigens in Raji cells.